Posts Tagged: "howard dean"

Will More Regulation Create Cheaper Drugs?

The idea of reducing drug prices through more government control is always simmering on the backburner and doesn’t require much to bring it to a full boil. Two recent actions turned up the heat to full blast. The response is often calls for more regulation, but ever increasing regulation benefits established players, which while inconvenienced, can afford to play the game. Start-ups can’t survive in endless oceans of red-tape that increase their costs while restricting market entry. Before rushing to impose more federal control, it might be wise to ask if government regulations inadvertently contribute to the problem.

Joseph Allen

October 20, 2015

Dishonest Roll Call Editorial on Follow on Biologics

Earlier today James Love and James Glassman published what can only be described as an intellectually dishonest op-ed piece on RollCall.com. The two James either simply do not understand patent law, the biologics legislation they detest or have an agenda that requires lying and obscuring the truth using scare tactics and falsehoods. I don’t really know whether they are as…

Gene Quinn

September 9, 2009

Howard Dean Supports Strong Protection for Biologics

Last week, on July 8, 2009, former Presidential Candidate, former Vermont Governor and former Chair of the Democratic National Committee, Howard Dean stepped into the health reform debate, discussing in an Op-ed piece published by TheHill.com. It is not surprising that Dean, who is a Medical Doctor and politician, would attempt to let his positions on health reform be known.…

Gene Quinn

July 14, 2009

Posts Tagged: "howard dean"

Varsity Sponsors

Latest IPW Posts

Updated WHO Pandemic Accord Retains Commitments for Non-Exclusive Licensing and Royalty Waivers

Tenth Circuit Reworks Opinion on Extraterritorial Reach of Lanham Act as Per SCOTUS

The SEP Couch: Lyse Brillouet on Managing SEPs and Open Standards

FTC Approves Final Rule to Ban All New Non-Compete Agreements in 3-2 Vote

The Briefing: Tennessee’s ELVIS Act – Is This Attempt to Protect Musicians (and Record Labels) in the AI Era Enforceable?

IPWatchdog Events

Artificial Intelligence Today: A Discussion of the Legal and Technical Landscape of AI (Replay)

Assessing Risks in AI Technologies (Replay)

Artificial Intelligence, Fair Use, and the Future of Copyright Law (Replay)

The Role of Trade Secret Protection for AI Related Data, Technology & Innovation (Replay)

Antitrust Challenges to Artificial Intelligence (Replay)

From IPWatchdog